MedPath

Targeting Low-voltage Areas with EGM-fractionation to Improve Outcome in Patients with Persistent Atrial Fibrillatio

Phase 4
Conditions
I48.1
Persistent atrial fibrillation
Registration Number
DRKS00012430
Lead Sponsor
niversitäts-Herzzentrum Freiburg Bad Krozingen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
290
Inclusion Criteria

• Patients with symptomatic persistent AF (>7 days and <12 months AF duration) undergoing a redo-ablation procedure (previous procedure(s) had to be PVI only).
• Age =18 years

Exclusion Criteria

• PVI with additional ablation targets (CFAE, lines other than CTI) during the previous ablation procedure(s)
• Paroxysmal AF (including patients that are cardioverted within 7 days after episode onset)
• Longstanding persistent AF (>12 months with a continuous episode of AF)
• Contra-indication to catheter ablation therapy
• LA-diameter >60 mm

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath